Publications by authors named "Ubong Peters"

Article Synopsis
  • The study aimed to assess the safety, tolerability, and effectiveness of inavolisib combined with palbociclib and endocrine therapy for patients with specific types of breast cancer.
  • A total of 53 patients participated, experiencing some treatment-related side effects, with common issues being stomatitis, hyperglycemia, and diarrhea, but overall the treatment was manageable.
  • Results showed promising preliminary antitumor activity, with objective response rates of about 52% and 40%, and median progression-free survival of 23.3 and 35.0 months for different treatment combinations.
View Article and Find Full Text PDF

The increase in asthma associated with the obesity epidemic cannot simply be due to airway hyperresponsiveness from chronic lung compression because chronic lung compression is a feature of obesity in general. We therefore sought to investigate what other factors might be at play in the impaired lung function seen in obese individuals with asthma. We measured respiratory system impedance in four groups-Lean Control, Lean Allergic Asthma, Obese Control, and Obese Allergic Asthma-before and after administration of albuterol.

View Article and Find Full Text PDF

There is a growing recognition that the clinical research enterprise has a diversity problem, given that many clinical trials recruit historically marginalized individuals or patients reflective of real-world data at a rate that is far below the incidence and prevalence of the disease for which the investigational therapy or device is targeting. This lack of diversity in clinical research participation can obscure the safety and efficacy of drug therapies and limits our collective ability to develop effective treatments for all patients, leading to even wider health disparities. This review article provides an in-depth analysis of the impact of this bias on public health, along with a description of some of the barriers that prevent historically marginalized populations from participating in clinical research.

View Article and Find Full Text PDF
Article Synopsis
  • Late-onset nonallergic asthma in obese people happens because their airways can close easily, which makes it hard to breathe.
  • Researchers wanted to see if a method called positive expiratory pressure (PEP) could help keep the airways open during asthma attacks caused by a chemical called methacholine.
  • The study found that using PEP helped reduce airway problems and made it easier for obese people with this type of asthma to breathe better, showing that PEP could be a useful treatment option.
View Article and Find Full Text PDF

Background And Objective: Late-onset non-allergic asthma in obesity is characterized by an abnormally compliant, collapsible lung periphery; it is not known whether this abnormality exists in proximal airways. We sought to compare collapsibility of central airways between lean and obese individuals with and without asthma.

Methods: A cross-sectional study comparing luminal area and shape (circularity) of the trachea, left mainstem bronchus, right bronchus intermedius and right inferior lobar bronchus at RV and TLC by CT was conducted.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers found that being very overweight can make people more likely to get asthma, especially a type called LONA asthma that happens later in life.
  • They studied how being overweight affects breathing and found that all overweight people had more trouble with their lungs, but those with LONA asthma had even bigger breathing problems.
  • The study also showed that overweight people with LONA asthma breathe faster and take in less air after challenging their lungs, and it’s still a mystery why only some overweight people develop this specific type of asthma.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates whether late-onset nonallergic asthma (LONA) in obese individuals has distinct physiological features compared to other groups, including lean controls and lean asthmatics.
  • Researchers conducted various lung function tests on four groups: Lean Control, Lean Asthma, Obese Control, and LONA Obese Asthma, to measure lung capacities and responses.
  • Results showed that LONA Obese Asthma had significantly lower forced vital capacity and reduced functional residual capacity, indicating unique challenges in lung function linked to obesity, while chronic lung compression affected all obese subjects equally.
View Article and Find Full Text PDF

Background And Objective: Obesity produces restrictive effects on lung function. We previously reported that obese patients with asthma exhibit a propensity towards small airway closure during methacholine challenge which improved with weight loss. We hypothesized that increased abdominal adiposity, a key contributor to the restrictive effects of obesity on the lung, mediates this response.

View Article and Find Full Text PDF

There is a major epidemic of obesity, and many obese patients suffer with respiratory symptoms and disease. The overall impact of obesity on lung function is multifactorial, related to mechanical and inflammatory aspects of obesity. Areas covered: Obesity causes substantial changes to the mechanics of the lungs and chest wall, and these mechanical changes cause asthma and asthma-like symptoms such as dyspnea, wheeze, and airway hyperresponsiveness.

View Article and Find Full Text PDF

Obesity and weight loss have complex effects on respiratory physiology, but these have been insufficiently studied, particularly at early time points following weight loss surgery and in the supine position. We evaluated 15 female participants with severe obesity before and 5 wk and 6 mo after bariatric surgery using the Pittsburgh Sleep Quality Index (PSQI), spirometry, plethysmography, and oscillometry to measure respiratory system mechanics. Oscillometry and spirometry were conducted in the upright and supine position and before and after bronchodilation with 200 µg of salbutamol.

View Article and Find Full Text PDF
Obesity and asthma.

J Allergy Clin Immunol

April 2018

Obesity is a vast public health problem and both a major risk factor and disease modifier for asthma in children and adults. Obese subjects have increased asthma risk, and obese asthmatic patients have more symptoms, more frequent and severe exacerbations, reduced response to several asthma medications, and decreased quality of life. Obese asthma is a complex syndrome, including different phenotypes of disease that are just beginning to be understood.

View Article and Find Full Text PDF

The multibreath nitrogen washout (MBNW) test, as it is currently practiced, provides parameters of potential physiological significance that are derived from the relationship between the volume-normalized Phase III slope of the exhaled nitrogen fraction ([Formula: see text]) vs. the cumulative change in lung volume (V). Reliable evaluation of these parameters requires, however, that the subject breathe deeply and evenly, so that Phase III can be clearly identified in every breath.

View Article and Find Full Text PDF

Obesity affects numerous diseases, including asthma, for reasons that remain incompletely understood. Recent research suggests that the asthma of obesity is not a single disease, and that it breaks out into at least two distinct phenotypes. One phenotype is conventional allergic asthma modulated by obesity, whereas another arises solely due to the presence of obesity.

View Article and Find Full Text PDF

The worldwide prevalence of obesity has increased rapidly in the last 3 decades, and this increase has led to important changes in the pathogenesis and clinical presentation of many common diseases. This review article examines the relationship between obesity and lung disease, highlighting some of the major findings that have advanced our understanding of the mechanisms contributing to this relationship. Changes in pulmonary function related to fat mass are important, but obesity is much more than simply a state of mass loading, and BMI is only a very indirect measure of metabolic health.

View Article and Find Full Text PDF

Obesity is associated with respiratory symptoms that are reported to improve with weight loss, but this is poorly reflected in spirometry, and few studies have measured respiratory mechanics with oscillometry. We investigated whether early changes in lung mechanics following weight loss are detectable with oscillometry. Furthermore, we investigated whether the changes in lung mechanics measured in the supine position following weight loss are associated with changes in sleep quality.

View Article and Find Full Text PDF